Barclays Upgrades Alvotech to Overweight, Raises Price Target to $8

Benzinga Newsdesk www.benzinga.com Positive 92.4%

Neg 0% Neu 0% Pos 92.4%

Barclays analyst Glen Santangelo upgrades Alvotech (NASDAQ:ALVO) from Underweight to Overweight and raises the price target from $4 to $8.